The Pharmacovigilance team at Stragen is responsible for monitoring the safety and efficacy of pharmaceutical products post-marketing. This team ensures compliance with regulatory requirements by collecting, analyzing, and reporting adverse event data. They work to identify potential safety concerns, mitigate risks, and ensure that any issues related to drug safety are addressed promptly, thereby safeguarding public health.